MKS Instruments Cash & Equivalents decreased by 15.7% to $569.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.1%, from $655.00M to $569.00M. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 2.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $755.20M | $633.30M | $966.00M | $1.01B | $1.07B | $884.00M | $909.00M | $880.00M | $757.00M | $859.00M | $875.00M | $845.00M | $850.00M | $861.00M | $714.00M | $655.00M | $674.00M | $697.00M | $675.00M | $569.00M |
| QoQ Change | — | -16.1% | +52.5% | +4.7% | +5.3% | -17.0% | +2.8% | -3.2% | -14.0% | +13.5% | +1.9% | -3.4% | +0.6% | +1.3% | -17.1% | -8.3% | +2.9% | +3.4% | -3.2% | -15.7% |
| YoY Change | — | — | — | — | +41.0% | +39.6% | -5.9% | -13.0% | -28.9% | -2.8% | -3.7% | -4.0% | +12.3% | +0.2% | -18.4% | -22.5% | -20.7% | -19.0% | -5.5% | -13.1% |